EMAIL DIGESTS
Daily
Every morning
Weekly
Sunday recap
Hemab is a biotechnology company pioneering the first preventative treatments and functional cures for patients with rare bleeding and thrombotic disorders.
No recent news for this company.
Hemab Therapeutics Closes $157M Series C Led by Sofinnova Partners
Hemab Therapeutics Raises $157M in Series C Led by Sofinnova Partners